CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Sanofi v. Alembic Pharmaceuticals Limited

1:14-cv-00424

Overview

Case Number 1:14-cv-00424
Filing Date 2014-04-04
Status Terminated
Termination Date 2016-09-22
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Alembic Limited NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Alembic Pharmaceuticals Limited NPE (University / Research)

Represented By

7 Attorneys Listed

Rachel C. Hughey

Email: rhughey@merchantgould.com

Michele Sherretta Budicak

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 571-6661

ADDRESS EXPIRED / UNKNOWN

Matthew L. Fedowitz

Email: matthew.fedowitz@bipc.com

Christopher J. Sorenson

Email: csorenson@merchantgould.com

Bruce J. Boggs

Email: jboggs@merchantgould.com

Adam Wyatt Poff

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Aaron M. Johnson

Email: ajohnson@taftlaw.com

Plaintiff

Sanofi-Aventis US LLC Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Sanofi Operating Company

Represented By

2 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 6 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): FR πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (6 found):
U.S. Courts: 6
U.S. District Court 2014-11-24
1:14-cv-01434

Sanofi v. Sandoz Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-07-03
1:14-cv-00875

Sanofi v. Amneal Pharmaceuticals LLC

Asserted Patent
Status: DED
U.S. District Court 2014-07-03
1:14-cv-00876

Sanofi v. Unimark Remedies Ltd.

Asserted Patent
Status: DED
U.S. District Court 2014-03-06
1:14-cv-00293

Sanofi v. First Time US Generics LLC

Asserted Patent
Status: DED
U.S. District Court 2014-03-06
1:14-cv-00292

Sanofi v. Alkem Laboratories Ltd.

Asserted Patent
Status: DED
U.S. District Court 2014-03-06
1:14-cv-00294

Sanofi v. Sun Pharma Global FZE

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7323493
Solid pharmaceutical composition containing benzofuran derivatives
Filed: 1998-06-19
Issued: 2008-01-29
Expired (Term Ended)
Expires: 2018-06-19
US8318800
Solid pharmaceutical compositions containing benzofuran derivatives
Filed: 2007-12-13
Issued: 2012-11-27
Expired (Term Ended)
Expires: 2019-06-15
US8410167
Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or of mortality
Filed: 2009-04-16
Issued: 2013-04-02
Active (2.4 yrs remaining)
Expires: 2029-04-16
US8602215
Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
Filed: 2011-06-30
Issued: 2013-12-10
Active (4.6 yrs remaining)
Expires: 2031-06-30

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

4

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 2 Claim Construction / Markman Filing 2

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending
Markman Hearing
Entry #β€” • 2015-08-20
Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 3/30/2015. Amended Pleadings due by 3/30/201...
Entry #20 • 2014-07-02 Document →
Procedural / Extension Motion Pending
SO ORDERED, re 11 STIPULATION TO EXTEND TIME for Defendant to answer, move or otherwise respond to Complaint to May 12, 2014, filed by Alembic Pharmaceuticals L...
Entry #β€” • 2014-04-28
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Defendant to answer, move or otherwise respond to Plaintiffs' Complaint to May 12, 2014 - filed by Alembic Pharmaceuticals Limite...
Entry #11 • 2014-04-25 Document →

Docket Entries

(38 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Alembic Limited, Alembic Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1492569.) - filed by Sanofi-Aventis US LLC, Sanofi. (Attachments: # 1 Exhibit A-D, # 2 Civil Cover Sheet)(cla, ) (Entered: 04/07/2014)

Entry #1 • 2014-04-04
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cla, ) (Entered: 04/07/2014)

Entry #2 • 2014-04-04
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,323,493 B1; 8,318,800 B2; 8,410,167 B2; 8,602,215 B2;. (cla, ) (Entered: 04/07/2014)

Entry #3 • 2014-04-04
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/1/14. Date of Expiration of Patent: SEE FORM.Thirty Month Stay Deadline: 1/1/2017. (cla, ) (Entered: 04/07/2014)

Entry #4 • 2014-04-04
1

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Sanofi-Aventis US LLC filed by Sanofi, Sanofi-Aventis US LLC. (cla, ) (Entered: 04/07/2014)

Entry #5 • 2014-04-04
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc